UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034634
Receipt number R000039443
Scientific Title Effects of perioperative administration of synthetic steroid on glycometabolism and insulin resistance
Date of disclosure of the study information 2018/10/25
Last modified on 2021/07/02 15:00:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of perioperative administration of synthetic steroid on glycometabolism and insulin resistance

Acronym

Effects of perioperative administration of synthetic steroid on glycometabolism and insulin resistance

Scientific Title

Effects of perioperative administration of synthetic steroid on glycometabolism and insulin resistance

Scientific Title:Acronym

Effects of perioperative administration of synthetic steroid on glycometabolism and insulin resistance

Region

Japan


Condition

Condition

preoperative management for oral, maxirofacial surgery and dental surgery

Classification by specialty

Anesthesiology Oral surgery Dental medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To study effects of administration of synthetic steroid during general anesthesia on postoperative hyperglycemia and insuline resistance



Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Postoperative Insulin Resistance

Key secondary outcomes

change of blood glucose nduring general anesthesia, blood test (lactate, free fatty acid,ketone body, catecholamine, 3-methylhistidine(indicator of muscle protein degradation,cortisol), serum electrolyte(Na+,K,Mg2+,Ca2+,Cl-),arterial blood gas (pH,PaCO2,PaO2,HCO3-,BE),urine glucose, urea nitrogen


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Synthetic steroid

Interventions/Control_2

Normal saline

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

written informed concent is obtained from patients who undergo oral surgery
aged from 20 to 50
ASA from 1 or 2
estimated operation time:3-7 hours

Key exclusion criteria

patients diagnosed with diabetes mellitus or disorder of carbohydrate metabolism
18.0>BMI BMI<=30
patients to who should not receive rinderon
patients whom reseachers consider inappropriate

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaori Tsukamoto

Organization

Kyushu University Hospital

Division name

Department of Dental Anesthesiology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan

TEL

0926426480

Email

tsukamoto@dent.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sayuri Kadowaki

Organization

Kyushu University Hospital

Division name

Department of Dental Anesthesiology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan

TEL

0926426480

Homepage URL


Email

s.koyama@dent.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Nikkiso Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

29049

Org. issuing International ID_1

Kyushu University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 05 Month 14 Day

Date of IRB

2018 Year 05 Month 14 Day

Anticipated trial start date

2018 Year 10 Month 26 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 25 Day

Last modified on

2021 Year 07 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039443


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name